Company Events & EarningsExtended setProductionNew
Published MAUDE reporting-cohort stress
Updated monthlyData needs: mediumshort only
In plain terms
Test whether a published change in a company’s device-report mix predicts stock weakness.
How it works
Internal hypothesis on a rise in death/injury report share within an exact-name reporting-manufacturer cohort in one independently observed FDA base file.
No live results for this strategy yet. Charts appear once it has earned a top spot on at least one stock, either on its own or as part of a blend of several strategies.
Loading substrate evidence…
Data dependencies
- Daily prices
Adjusted-close OHLCV for every US-listed ticker; primary price feed.
- Maude reporting cohort snapshots
A data feed this strategy reads, refreshed on its normal schedule.
Expected edge
See the source research for the original effect size; a modern replication on new data may be weaker.
Example tickers where this is likely to fire
Illustrative only, the signal fires based on the live data, not a fixed list.
Related families
Explore Published MAUDE reporting-cohort stress on alphactor.ai
See which tickers this family is currently firing on, with live signals and rankings.